Live Chart

Chart is not available for Mesco Pharmaceuticals. Please visit after some time.

Mesco Pharmaceuticals Performance

Days Range

Low: ₹4.54
High: ₹4.54
Previous Close ₹4.33
Open ₹4.54
Volume 700
Day’s Range ₹4.54 - ₹4.54
52W Range ₹0.00 - ₹4.54
Market Cap ₹9.23 Cr

Fundamentals of Mesco Pharmaceuticals

ROCE (TTM) NA
P/E Ratio (TTM) NA
P/B Ratio NA
Industry P/E NA
Debt to Equity NA
ROE NA
EPS (TTM) NA
Dividend Yield NA
Book Value NA
Face Value NA

Financials of Mesco Pharmaceuticals

Financials data is not available for Mesco Pharmaceuticals. Please visit after some time.

About Mesco Pharmaceuticals

Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bu ... Read More

Parent Organisation Mesco
Founded 1986
Managing Director
BSE Symbol MESPHAR-B

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,859.15

350.05

5.95 (-1.67%)

347.2 - 362.7
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹50.54

47.2

1.25 (2.72%)

46.5 - 47.45
Procter & Gamble Health Ltd ₹8,348.56

5050.1

12.65 (0.25%)

5011.5 - 5067.95
Veerhealth Care Ltd ₹45.02

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Mesco Pharmaceuticals (MESPHAR-B)?

Mesco Pharmaceuticals (MESPHAR-B) share price as of February 29, 2000, on NSE is Rs 5.35 (NSE) and Rs 4.54 (BSE) on BSE.

Can I buy Mesco Pharmaceuticals (MESPHAR-B) shares?

Yes, You can buy Mesco Pharmaceuticals (MESPHAR-B) shares by opening a Demat account with Angel One.

How do I buy Mesco Pharmaceuticals (MESPHAR-B) from Angel One?

Mesco Pharmaceuticals (MESPHAR-B) share can be brought through the following modes:
  1. Direct investment: You can buy Mesco Pharmaceuticals (MESPHAR-B) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Mesco Pharmaceuticals (MESPHAR-B) shares.